Role of thermodynamic, molecular, and kinetic factors in crystallization from the amorphous state

被引:367
作者
Bhugra, Chandan [1 ]
Pikal, Michael J. [1 ]
机构
[1] Univ Connecticut, Sch Pharm, Dept Pharmaceut Sci, Storrs, CT 06269 USA
关键词
amorphous state; crystallization; molecular mobility in glasses; stability; nucleation; preparation of amorphous solids; thermodynamics of crystallization;
D O I
10.1002/jps.21138
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Though there is an advantage in using the higher solubility amorphous state in cases where low solubility limits absorption, physical instability poses a significant barrier limiting its use in solid oral dosage forms. Unlike chemical instability, where useful accelerated stability testing protocols are common, no methodology has been established to predict physical instability. Therefore, an understanding of the factors affecting crystallization from the amorphous state is not only important from a scientific perspective but also has practical applications. Crystallization from the amorphous matrix has been linked to the molecular mobility in the amorphous matrix and recent research has focused on developing the link between these two fundamental properties of glass forming materials. Although researchers have been actively working in this area for some time, there is no current review describing the present state of understanding of crystallization from the amorphous state. The purpose of this review therefore is to examine the roles of different factors such as molecular mobility, thermodynamic factors, and the implication of different processing condition, in crystallization from the amorphous state. We believe an increased understanding of the relative contributions of molecular mobility and processing conditions are vital to increased usage of the amorphous state in solid oral dosage forms. (C) 2007 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:1329-1349, 2008.
引用
收藏
页码:1329 / 1349
页数:21
相关论文
共 91 条
[1]   Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance [J].
Alie, J ;
Menegotto, J ;
Cardon, P ;
Duplaa, H ;
Caron, A ;
Lacabanne, C ;
Bauer, M .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (01) :218-233
[2]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[3]   Crystal nucleation and growth of indomethacin polymorphs from the amorphous state [J].
Andronis, V ;
Zografi, G .
JOURNAL OF NON-CRYSTALLINE SOLIDS, 2000, 271 (03) :236-248
[4]   Effects of sorbed water on the crystallization of indomethacin from the amorphous state [J].
Andronis, V ;
Yoshioka, M ;
Zografi, G .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (03) :346-351
[5]  
ANGELL CA, 2004, BIOTECHNOL PHARM ASP, V2, P367
[6]   Characterisation of indomethacin and nifedipine using variable-temperature solid-state NMR [J].
Apperley, DC ;
Forster, AH ;
Fournier, R ;
Harris, RK ;
Hodgkinson, P ;
Lancaster, RW ;
Rades, T .
MAGNETIC RESONANCE IN CHEMISTRY, 2005, 43 (11) :881-892
[7]  
Aso Y, 2000, J PHARM SCI, V89, P408, DOI 10.1002/(SICI)1520-6017(200003)89:3<408::AID-JPS11>3.0.CO
[8]  
2-#
[9]   Molecular mobility-based estimation of the crystallization rates of amorphous nifedipine and phenobarbital in poly(vinylpyrrolidone) solid dispersions [J].
Aso, Y ;
Yoshioka, S ;
Kojima, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 93 (02) :384-391
[10]   Feasibility of using isothermal microcalorimetry to evaluate the physical stability of amorphous nifedipine and phenobarbital [J].
Aso, Y ;
Yoshioka, S ;
Kojima, S .
THERMOCHIMICA ACTA, 2001, 380 (02) :199-204